A Virginia Republican-led House Appropriations Committee agreed to expand enrollment in the state’s Medicaid program, imposing tougher work requirements on recipients in an attempt at gaining acceptance in the state Senate; there’s a growing industry that makes money by coaxing women into having surgery to remove their vaginal mesh implants, sometimes unnecessarily; HHS Secretary Alex Azar was admitted to a hospital after suffering "a minor infection."
A Virginia Republican-led House Appropriations Committee agreed to expand enrollment in the state’s Medicaid program Friday, imposing tougher work requirements on recipients in an attempt at gaining acceptance in the state Senate, and adding new provisions aimed at shoring up the individual insurance market, The Washington Post reported. State budget talks collapsed last month over a Medicaid standoff. The House wanted to let an additional 400,000 low-income Virginians enroll, but the Senate was opposed.
There’s a growing industry that makes money by coaxing women into having surgery to remove their vaginal mesh implants, sometimes unnecessarily, so that they are more lucrative plaintiffs in lawsuits against medical device manufacturers, The New York Times reported over the weekend. At the center are marketing firms, which drum up women on behalf of lawyers. The marketers turn to finance companies to provide high-interest loans to the clients that have to be repaid only if the clients receive money from the case. Those loans are then used to pay for surgery performed by doctors who are recruited by the marketers. The Times said the system is backed by banks, private equity firms, and hedge funds. The women are often left with physicial or mental problems post surgery.
HHS Secretary Alex Azar was admitted to a hospital after suffering "a minor infection" and was treated with intravenous antibiotics, HHS told Politico Sunday night. Azar was admitted "out of an abundance of caution" to undergo observation. HHS would not disclose the hospital or additional information, citing privacy concerns.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
FDA Expands Access to Approved CAR T-Cell Therapies by Eliminating REMS
June 30th 2025The FDA has removed Risk Evaluation and Mitigation Strategies (REMS) for approved chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, aiming to ease provider burden and expand patient access.
Read More
Allergies and Asthma Prevalence Rise With Climate Change Extremes and Pollutants
June 30th 2025Increasing environmental events driven by climate change and human activity exacerbate allergy and asthma conditions, further compounded by exposure to persistent pollutants like per-and polyfluoroalkyl substances and microplastics.
Read More